Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentrica Regulatory News (CNA)

Share Price Information for Centrica (CNA)

Share Price is delayed by 15 minutes
Get Live Data
185.80    0.70 (0.38%)
Bid:
185.70
Ask:
185.85
Spread: 0.15 (0.081%)
Market Cap: £8.41b
CNA Live PriceLast checked at - London Stock Exchange

Intraday Centrica Share Chart

AGM Statement

7 May 2026 07:00

RNS Number : 3227D
Centrica PLC
07 May 2026
 

7 May 2026

Centrica plc

AGM Statement

Centrica plc (the "Company") will hold its Annual General Meeting today at 10.30am at The Parkgate Hotel, Westgate Street, Cardiff, CF10 1DA.

Ahead of the Company's 2026 Interim Results, which will be released on 23 July 2026, the Company provides the following update on its performance.

Centrica continues to make good progress on the execution of its strategy, including investing for value through its organic pipeline and the c.£370m acquisition of the 850MW Severn power station1, as well as continuing to progress its transformation programme. For the 2026 full year we expect:

· Capital investment in 2026 to be around £1.1bn.

· Retail EBITDA to be towards the lower end of its guidance range2, reflecting the impact of warmer weather year-to-date, the shape of the commodity price curve and continued challenges in residential energy bad debt collection.

· No change to Optimisation EBITDA guidance3.

· Infrastructure EBITDA to be above the top end of its guidance range4, predominantly supported by higher realised prices.

· Within Infrastructure, continued strong performance from the Meter Asset Provider ("MAP"), which is on-track to install over 1m meters in 2026. The expected EBITDA contribution for the year from MAP, Sizewell C and Grain LNG is unchanged at around £175m.

· The outlook is subject to the usual uncertainties for the balance of the year, including weather, commodity prices, regulation and government policy. We also continue to monitor the impact of the ongoing conflict in the Middle East.

Enquiries:

Investors and Analysts: email: ir@centrica.com

Media: email: media@centrica.com tel: +44 (0)1784 843000 

 

Notes:

1. Announced 7 May 2026, further details available here: www.centrica.com/severn. All guidance commentary includes Severn, which is expected to make a small net loss in 2026 due to transaction and integration costs, alongside naturally lower revenues in the summer months. From 2027 onwards Severn is expected to contribute £30m - 60m of EBITDA per annum.2. Retail adjusted EBITDA guidance range of £500m - £800m.3. Optimisation adjusted EBITDA of around £250m.4. Infrastructure adjusted EBITDA guidance range of £500m - £650m.

 

Centrica plc is listed on the London Stock Exchange (CNA)Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654Legal Entity Identifier number: E26EDV109X6EEPBKVH76ISIN number: GB00B033F229

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMBQLLBQELEBBF
Date   Source Headline
25th May 202311:20 amRNSDirector/PDMR Shareholding
24th May 20236:15 pmRNSTransaction in Own Shares
23rd May 20236:25 pmRNSTransaction in Own Shares
22nd May 20236:10 pmRNSTransaction in Own Shares
19th May 20236:20 pmRNSTransaction in Own Shares
19th May 20235:00 pmRNSHolding(s) in Company
19th May 202310:00 amRNSHolding(s) in Company
18th May 20236:30 pmRNSTransaction in Own Shares
18th May 20238:00 amRNSInvestor and Analyst Teach-in
17th May 20236:15 pmRNSTransaction in Own Shares
17th May 20236:00 pmRNSHolding(s) in Company
16th May 20236:15 pmRNSTransaction in Own Shares
16th May 202310:30 amRNSHolding(s) in Company
15th May 20236:15 pmRNSTransaction in Own Shares
12th May 20236:20 pmRNSTransaction in Own Shares
12th May 20234:00 pmRNSHolding(s) in Company
12th May 202310:00 amRNSHolding(s) in Company
11th May 20236:00 pmRNSTransaction in Own Shares
11th May 20233:33 pmRNSNotice of AGM
11th May 20231:30 pmRNSDirector/PDMR Shareholding
11th May 202310:00 amRNSHolding(s) in Company
10th May 20236:10 pmRNSTransaction in Own Shares
9th May 20236:20 pmRNSTransaction in Own Shares
9th May 20233:45 pmRNSHolding(s) in Company
9th May 202310:00 amRNSHolding(s) in Company
5th May 20236:10 pmRNSTransaction in Own Shares
4th May 20236:15 pmRNSTransaction in Own Shares
4th May 20235:15 pmRNSHolding(s) in Company
3rd May 20236:20 pmRNSTransaction in Own Shares
3rd May 20235:15 pmRNSHolding(s) in Company
2nd May 20236:20 pmRNSTransaction in Own Shares
2nd May 20233:30 pmRNSHolding(s) in Company
2nd May 202311:30 amRNSBlock listing Interim Review
2nd May 202311:15 amRNSTotal Voting Rights
28th Apr 20236:20 pmRNSTransaction in Own Shares
27th Apr 20236:00 pmRNSTransaction in Own Shares
27th Apr 20235:30 pmRNSHolding(s) in Company
27th Apr 20235:00 pmRNSHolding(s) in Company
27th Apr 202310:00 amRNSHolding(s) in Company
26th Apr 20236:15 pmRNSTransaction in Own Shares
25th Apr 20236:15 pmRNSTransaction in Own Shares
25th Apr 20234:30 pmRNSDirector/PDMR Shareholding
24th Apr 20236:25 pmRNSTransaction in Own Shares
21st Apr 20236:15 pmRNSTransaction in Own Shares
21st Apr 20232:15 pmRNSHolding(s) in Company
20th Apr 20236:15 pmRNSTransaction in Own Shares
19th Apr 20236:16 pmRNSTransaction in Own Shares
18th Apr 20236:10 pmRNSTransaction in Own Shares
17th Apr 20236:25 pmRNSTransaction in Own Shares
17th Apr 20235:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.